Conduit Pharmaceuticals Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
CDT, CDTTW on Nasdaq
Location
4851 Tamiami Trail North, Suite 200, Naples, FL

Insiders trading volume in the past year

Conduit Pharmaceuticals Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jack Heilbron Former CEO,director&10% owner $9.19M Sep 22, 2023
Andrew Regan Chief Executive Officer, Director, 10%+ Owner $1M Sep 19, 2025
James Bligh CFO, Director $822K Sep 19, 2025
Nirland Ltd 10%+ Owner $626K -$96.5K -13.4% Oct 3, 2024
Faith L. Charles Director $173K Apr 16, 2025
Sarborg Ltd 10%+ Owner $83.8K Mar 31, 2025
Freda Lewis-Hall Director $82.2K Aug 5, 2025
Chele Chiavacci Farley Director $80.3K Aug 5, 2025
Simon Jeremy Fry Director $79.7K Aug 5, 2025
David Tapolczay Chief Executive Officer, Director $77.2K Nov 18, 2024
Jennifer Isacoff McNealey Director $0 May 13, 2024
Adam Sragovicz Chief Financial Officer May 15, 2024
Murphy Canyon Acquisition Sponsor, LLC 10%+ Owner Feb 2, 2022
Shaolin Capital Management LLC 10%+ Owner Feb 3, 2023
Edwin Bentzen Chief Accounting Officer Feb 2, 2022
Francis Knuettel II Director Feb 2, 2022
Richard E. Feinberg Director Feb 2, 2022

Recent Insider Transactions by Companies or Individuals for Conduit Pharmaceuticals Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.